AGTI · Agiliti, Inc. \de - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $302.75M | - | $291.63M | $291.08M | $299.90M | - | $271.19M | $273.98M | $294.44M | - |
| Cost of Revenue | $203.54M | - | $194.88M | $191.68M | $190.53M | - | $169.58M | $175.82M | $170.82M | - |
| Gross Profit | $99.21M | - | $96.76M | $99.40M | $109.37M | - | $101.60M | $98.17M | $123.63M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $84.03M | - | $87.30M | $81.23M | $88.84M | - | $86.04M | $82.12M | $86.14M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $20.98M | - | $20.30M | $19.50M | $19.62M | - | $19.10M | $23.90M | $22.50M | - |
| Operating Income | $15.18M | - | $9.46M | $18.17M | $20.54M | - | $15.56M | $16.04M | $37.49M | - |
| Interest Expense | $22.92M | - | $24.27M | $20.55M | $15.83M | - | $12.53M | $11.26M | $10.66M | - |
| Income Tax | ($1.22M) | - | ($2.27M) | ($2.89M) | $1.66M | - | ($10.88M) | ($1.70M) | $6.91M | - |
| Net Income | ($6.61M) | - | ($12.70M) | ($4.03M) | $3.01M | - | $1.95M | $5.00M | $19.89M | - |
| EPS - Basic | ($0.05) | - | ($0.09) | ($0.03) | $0.02 | - | $10000.00 | $40000.00 | $0.15 | - |
| EPS - Diluted | ($0.05) | - | ($0.09) | ($0.03) | $0.02 | - | $10000.00 | $40000.00 | $0.14 | - |
Balance Sheet
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.37M | $20.04M | $30.39M | $9.21M | $14.45M | $5.58M | $32.21M | $16.52M | $52.10M | $74.33M |
| Accounts Receivable | $246.34M | $215.68M | $212.99M | $220.27M | $222.85M | $207.75M | $203.09M | $215.86M | $213.55M | $209.31M |
| Inventory | $86.01M | $74.48M | $79.19M | $79.15M | $73.58M | $70.13M | $60.99M | $59.14M | $55.95M | $55.31M |
| Accounts Payable | $67.71M | $58.52M | $71.00M | $70.33M | $69.43M | $59.16M | $59.09M | $56.51M | $57.45M | $53.85M |
| Current Assets | $363.38M | $337.74M | $344.20M | $328.82M | $333.64M | $316.31M | $330.79M | $318.75M | $342.67M | $357.88M |
| Total Assets | $2.41B | $2.40B | $2.42B | $2.43B | $2.44B | $2.44B | $2.42B | $2.44B | $2.49B | $2.52B |
| Current Liabilities | $216.18M | $196.61M | $211.70M | $180.69M | $197.16M | $197.38M | $200.92M | $189.93M | $203.55M | $208.53M |
| Long-term Debt | $1.09B | $1.08B | $1.08B | $1.10B | $1.10B | $1.10B | $1.07B | $1.09B | $1.12B | $1.19B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $939.73M | $940.56M | $944.24M | $954.19M | $947.02M | $946.13M | $936.34M | $928.54M | $925.90M | $895.95M |
| Retained Earnings | ($40.31M) | ($33.70M) | ($27.99M) | ($15.29M) | ($11.26M) | ($14.27M) | ($17.64M) | ($19.60M) | ($24.59M) | ($44.49M) |
Cash Flow
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $13.76M | - | - | - | $54.90M | - | - | - | $67.12M | - |
| Investing Cash Flow | ($17.77M) | - | - | - | ($17.83M) | - | - | - | ($14.58M) | - |
| Financing Cash Flow | ($10.66M) | - | - | - | ($28.19M) | - | - | - | ($74.77M) | - |
| CapEx | $6.67M | - | - | - | $6.73M | - | - | - | $5.21M | - |
| Free Cash Flow | $7.09M | - | - | - | $48.16M | - | - | - | $61.91M | - |
Ratios
| Metric | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 32.8% | - | 33.2% | 34.1% | 36.5% | - | 37.5% | 35.8% | 42.0% | - |
| Operating margin | 5.0% | - | 3.2% | 6.2% | 6.8% | - | 5.7% | 5.9% | 12.7% | - |
| EBITDA margin | 11.9% | - | 10.2% | 12.9% | 13.4% | - | 12.8% | 14.6% | 20.4% | - |
| Net margin | -2.2% | - | -4.4% | -1.4% | 1.0% | - | 0.7% | 1.8% | 6.8% | - |
| Free cash flow margin | 2.3% | - | - | - | 16.1% | - | - | - | 21.0% | - |
| FCF / Net income | -1.07 | - | - | - | 15.98 | - | - | - | 3.11 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 27.8% | - | 29.9% | 27.9% | 29.6% | - | 31.7% | 30.0% | 29.3% | - |
| Effective tax rate | - | - | - | - | 35.5% | - | - | -51.5% | 25.8% | - |
| Return on assets | -0.3% | - | -0.5% | -0.2% | 0.1% | - | 0.1% | 0.2% | 0.8% | - |
| Return on equity | -0.7% | - | -1.3% | -0.4% | 0.3% | - | 0.2% | 0.5% | 2.1% | - |
| Return on invested capital | 0.6% | - | 0.4% | 0.7% | 0.6% | - | 0.6% | 0.8% | 1.4% | - |
| Liquidity | ||||||||||
| Current ratio | 1.68 | 1.72 | 1.63 | 1.82 | 1.69 | 1.60 | 1.65 | 1.68 | 1.68 | 1.72 |
| Quick ratio | 1.28 | 1.34 | 1.25 | 1.38 | 1.32 | 1.25 | 1.34 | 1.37 | 1.41 | 1.45 |
| Cash ratio | 0.02 | 0.10 | 0.14 | 0.05 | 0.07 | 0.03 | 0.16 | 0.09 | 0.26 | 0.36 |
| Leverage | ||||||||||
| Debt / Equity | 1.16 | 1.15 | 1.14 | 1.15 | 1.16 | 1.16 | 1.14 | 1.17 | 1.21 | 1.33 |
| Debt / Assets | 0.45 | 0.45 | 0.45 | 0.45 | 0.45 | 0.45 | 0.44 | 0.45 | 0.45 | 0.47 |
| Debt / EBITDA | 30.02 | - | 36.23 | 29.13 | 27.43 | - | 30.81 | 27.31 | 18.70 | - |
| Interest coverage | 0.7x | - | 0.4x | 0.9x | 1.3x | - | 1.2x | 1.4x | 3.5x | - |
| Equity multiplier | 2.56 | 2.55 | 2.56 | 2.54 | 2.58 | 2.58 | 2.58 | 2.63 | 2.69 | 2.81 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.13 | - | 0.12 | 0.12 | 0.12 | - | 0.11 | 0.11 | 0.12 | - |
| Inventory turnover | 2.37 | - | 2.46 | 2.42 | 2.59 | - | 2.78 | 2.97 | 3.05 | - |
| Days sales outstanding | 297d | - | 267d | 276d | 271d | - | 273d | 288d | 265d | - |
| Days inventory outstanding | 154d | - | 148d | 151d | 141d | - | 131d | 123d | 120d | - |
| Days payable outstanding | 121d | - | 133d | 134d | 133d | - | 127d | 117d | 123d | - |
| Cash conversion cycle | 330d | - | 282d | 293d | 279d | - | 277d | 293d | 262d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 0.9% | - | 7.5% | 6.2% | 1.9% | - | 39.3% | 9.4% | 64.3% | - |
| Revenue CAGR (3y) | 19.1% | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -9.3% | - | -4.8% | 1.3% | -11.5% | - | 36.2% | -1.0% | 113.9% | - |
| Operating income growth (YoY) | -26.1% | - | -39.2% | 13.3% | -45.2% | - | 441.4% | -11.1% | 2920.9% | - |
| Net income growth (YoY) | - | - | - | - | -84.9% | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | -85.7% | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -85.3% | - | - | - | -22.2% | - | - | - | 150.9% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -0.8% | -0.6% | 0.8% | 2.8% | 2.3% | 5.6% | 6.9% | 7.7% | 109.6% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Product / service
$1.17B totalEquipment Solutions$459.80M · 39.1%
Clinical Engineering$459.01M · 39.1%
On Site Managed Services$255.79M · 21.8%
Peer comparison
Same SIC group: Services-Miscellaneous Equipment Rental & Leasing
Comparing AGILITI against the 5 most active filers in the same SIC group.